A bioactivated in vivo assembly nanotechnology fabricated NIR probe for small pancreatic tumor intraoperative imaging.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-021-27932-y
- By:
- Publication type:
- Article
Works matching AU Hou, Da‐Yong
Results: 15
1
2
Programmable Peptides Activated Macropinocytosis for Direct Cytosolic Delivery.
- Published in:
- Advanced Healthcare Materials, 2023, v. 12, n. 27, p. 1, doi. 10.1002/adhm.202301162
- By:
- Publication type:
- Article
3
Conformational Transition‐Triggered Disassembly of Therapeutic Peptide Nanomedicine for Tumor Therapy.
- Published in:
- Advanced Healthcare Materials, 2021, v. 10, n. 24, p. 1, doi. 10.1002/adhm.202100333
- By:
- Publication type:
- Article
4
Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy.
- Published in:
- Angewandte Chemie International Edition, 2023, v. 62, n. 37, p. 1, doi. 10.1002/anie.202308049
- By:
- Publication type:
- Article
5
In Situ Constructed Nano‐Drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer.
- Published in:
- Angewandte Chemie International Edition, 2022, v. 61, n. 18, p. 1, doi. 10.1002/anie.202116893
- By:
- Publication type:
- Article
6
Nano Proteolysis Targeting Chimeras (PROTACs) with Anti‐Hook Effect for Tumor Therapy.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 37, p. 1, doi. 10.1002/ange.202308049
- By:
- Publication type:
- Article
7
In Situ Constructed Nano‐Drug Depots through Intracellular Hydrolytic Condensation for Chemotherapy of Bladder Cancer.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 18, p. 1, doi. 10.1002/ange.202116893
- By:
- Publication type:
- Article
8
Controllable Self‐Assembly of Peptide‐Cyanine Conjugates In Vivo as Fine‐Tunable Theranostics.
- Published in:
- Angewandte Chemie, 2021, v. 133, n. 14, p. 7888, doi. 10.1002/ange.202015126
- By:
- Publication type:
- Article
9
Inducing mitochondriopathy-like damages by transformable nucleopeptide nanoparticles for targeted therapy of bladder cancer.
- Published in:
- National Science Review, 2024, v. 11, n. 4, p. 1, doi. 10.1093/nsr/nwae028
- By:
- Publication type:
- Article
10
A Transformable Specific‐Responsive Peptide for One‐Step Synergistic Therapy of Bladder Cancer.
- Published in:
- Small, 2024, v. 20, n. 35, p. 1, doi. 10.1002/smll.202310416
- By:
- Publication type:
- Article
11
Tumor‐Specific Protein Induced in Situ Self‐Assembly of Peptide Drugs for Synergistic Mitochondria Disruption.
- Published in:
- Advanced Materials, 2025, v. 37, n. 3, p. 1, doi. 10.1002/adma.202413069
- By:
- Publication type:
- Article
12
An In Vivo Self‐Assembled Bispecific Nanoblocker for Enhancing Tumor Immunotherapy.
- Published in:
- Advanced Materials, 2023, v. 35, n. 45, p. 1, doi. 10.1002/adma.202303831
- By:
- Publication type:
- Article
13
Reprogramming Hypoxic Tumor‐Associated Macrophages by Nanoglycoclusters for Boosted Cancer Immunotherapy.
- Published in:
- Advanced Materials, 2023, v. 35, n. 24, p. 1, doi. 10.1002/adma.202211332
- By:
- Publication type:
- Article
14
A Polyvalent Peptide CD40 Nanoagonist for Targeted Modulation of Dendritic Cells and Amplified Cancer Immunotherapy.
- Published in:
- Advanced Materials, 2022, v. 34, n. 24, p. 1, doi. 10.1002/adma.202109432
- By:
- Publication type:
- Article
15
Controllable Self‐Assembly of Peptide‐Cyanine Conjugates In Vivo as Fine‐Tunable Theranostics.
- Published in:
- Angewandte Chemie International Edition, 2021, v. 60, n. 14, p. 7809, doi. 10.1002/anie.202015126
- By:
- Publication type:
- Article